These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28862188)

  • 21. Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance.
    Bortoletto G; Scribano L; Realdon S; Marcolongo M; Mirandola S; Franceschini L; Bonisegna S; Noventa F; Plebani M; Martines D; Alberti A
    J Viral Hepat; 2010 Jul; 17(7):475-80. PubMed ID: 19878535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained virological response following chronic hepatitis C treatment is associated with improvement in insulin resistance.
    Chan CH; Hansen RD; Gilliver RS; Jones BE
    Intern Med J; 2013 Jun; 43(6):656-62. PubMed ID: 23506416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin.
    Elefsiniotis IS; Pavlidis C; Ketikoglou I; Koutsounas S; Scarmeas N; Pantazis KD; Moulakakis A; Tsianos EV
    Eur J Intern Med; 2008 Jun; 19(4):266-70. PubMed ID: 18471675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum leptin and ghrelin in chronic hepatitis C patients with steatosis.
    Pavlidis C; Panoutsopoulos GI; Tiniakos D; Koutsounas S; Vlachogiannakos J; Zouboulis-Vafiadis I
    World J Gastroenterol; 2011 Dec; 17(46):5097-104. PubMed ID: 22171144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.
    Aghemo A; Prati GM; Rumi MG; Soffredini R; D'Ambrosio R; Orsi E; De Nicola S; Degasperi E; Grancini V; Colombo M
    Hepatology; 2012 Nov; 56(5):1681-7. PubMed ID: 22619107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C.
    Gad RR; Males S; El Makhzangy H; Shouman S; Hasan A; Attala M; El Hoseiny M; Zalata K; Abdel-Hamid M; Fontanet A; Mohamed MK; Esmat G
    Liver Int; 2008 Sep; 28(8):1112-9. PubMed ID: 18397226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1.
    Petta S; Amato M; Cabibi D; Cammà C; Di Marco V; Giordano C; Galluzzo A; Craxì A
    Hepatology; 2010 Nov; 52(5):1543-52. PubMed ID: 20799355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4.
    Khattab MA; Eslam M; Shatat M; Abd-Aalhalim H; Mousa YI; Samir F; Aly H; Shaker O; Shaker Y
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):59-65. PubMed ID: 22457861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
    Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
    Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C.
    Pattullo V; Ravindran NC; Mazzulli T; Wong DK; Heathcote EJ
    J Viral Hepat; 2010 Dec; 17(12):834-8. PubMed ID: 20196800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.
    Chang ML; Kuo CJ; Pao LH; Hsu CM; Chiu CT
    Virulence; 2017 Oct; 8(7):1255-1264. PubMed ID: 28267407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum inducible protein-10 chemokine as a biomarker for clearance of HCV with and without treatment in Egyptian patients.
    Tabll A; El Shenawy R; Elsharkawy H; Mohamed FZ
    Hum Antibodies; 2019; 27(4):265-273. PubMed ID: 31127759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.
    Petta S; Handberg A; Marchesini G; Cammà C; Di Marco V; Cabibi D; Macaluso FS; Craxì A
    J Viral Hepat; 2013 Mar; 20(3):174-82. PubMed ID: 23383656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance.
    Khattab M; Emad M; Abdelaleem A; Eslam M; Atef R; Shaker Y; Hamdy L
    Liver Int; 2010 Mar; 30(3):447-54. PubMed ID: 19919569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response.
    Tachi Y; Hirai T; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
    J Gastroenterol Hepatol; 2016 May; 31(5):1001-8. PubMed ID: 27123974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance.
    Yu JW; Sun LJ; Zhao YH; Kang P; Yan BZ
    Int J Infect Dis; 2012 Jun; 16(6):e436-41. PubMed ID: 22486858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis C.
    Neumann AU; Bain VG; Yoshida EM; Patel K; Pulkstenis E; Subramanian GM
    Liver Int; 2009 Oct; 29(9):1350-5. PubMed ID: 19291180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.
    Jian Wu Y; Shu Chen L; Gui Qiang W
    Liver Int; 2006 Mar; 26(2):166-72. PubMed ID: 16448454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.
    Serfaty L; Forns X; Goeser T; Ferenci P; Nevens F; Carosi G; Drenth JP; Lonjon-Domanec I; DeMasi R; Picchio G; Beumont M; Marcellin P
    Gut; 2012 Oct; 61(10):1473-80. PubMed ID: 22387529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demographic profile, host, disease & viral predictive factors of response in patients with chronic hepatitis C virus infection at a tertiary care hospital in north India.
    Vasudevan S; ; Kavimandan A; Kalra N; Nayak B; Thakur B; Das P; Gupta SD; Panda SK; Acharya SK
    Indian J Med Res; 2016 Mar; 143(3):331-40. PubMed ID: 27241647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.